J&J Publishes Its Annual Transparency Report, Discloses It Gave Back 58% of Sales in Rebates, Discounts, and Fees
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
The Colorado Prescription Drug Affordability Board blinked. On Friday, they had a chance to deem Vertex’s CF drug, Trikafta, as the first-ever “unaffordable” medicine, thereby opening the medicine to price
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv